PATENT CLAIM ANALYSIS

Application Number: 16201505
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "489000"]

Abstract:
Provided herein are methods of inhibiting proliferation of one or more tumor cells comprising contacting the one or more tumor cells with a composition comprising one or more epigenetic drugs that inhibit one or more epigenetic mechanisms of the tumor cells, wherein the one or more epigenetic drugs are encapsulated in a nanogel. The invention is also directed to methods of treating a tumor, metastasis of a tumor or a combination thereof in an individual in need thereof. The invention is also directed to a method of sequentially delivering one or more epigenetic drugs that alter one or more epigenetic mechanisms of a tumor cell and one or more chemotherapeutic drugs to an individual that has a tumor. Compositions which comprise one or more epigenetic drugs that alter one or more epigenetic mechanisms of a tumor cell, wherein the one or more epigenetic drugs are encapsulated in a nanogel.

Claim (Index 2):
The composition of  claim 1  further comprising one or more chemotherapeutic drugs encapsulated in a nanogel.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 98.0
- Lexical Diversity: 2.9434
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15011467', '13929981', '15069311', '15427017', '14118224']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6484806319926798
- 35 USC 102 Novelty (BERT): 0.5608129624467646
- Combined Prediction Score: 0.6397138650380884
- Mean Citation Score: 233.729464
- Max Citation Score: 443.262
- Similarity Product: 305.6308549171686

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test